FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133797170> ?p ?o ?g. }

• W3133797170 endingPage "1209" @default.
• W3133797170 startingPage "1200" @default.
• W3133797170 abstract "Significance Statement Although young adults (aged 18–40 years) with CKD are at risk for poor cardiovascular and renal outcomes, with hypertension an important and potentially modifiable risk factor, they are largely absent from observational studies and clinical trials of BP in patients with CKD. To address this knowledge gap, this observational study provides a description of BP and its relation to outcomes specifically in young adults with CKD. It demonstrates that among young adults with CKD, higher BP is associated with cardiovascular events (particularly heart failure) and CKD progression. The study’s findings may provide a foundation for future work to develop best practices for BP management in young adults with CKD and improve outcomes. Background BP is an important modifiable risk factor for cardiovascular events and CKD progression in middle-aged or older adults with CKD. However, studies describing the relationship between BP with outcomes in young adults with CKD are limited. Methods In an observational study, we focused on 317 young adults (aged 21–40 years) with mild to moderate CKD enrolled in the Chronic Renal Insufficiency Cohort (CRIC) Study. Exposures included baseline systolic BP evaluated continuously (per 10 mm Hg increase) and in categories (<120, 120–129, and ≥130 mm Hg). Primary outcomes included cardiovascular events (heart failure, myocardial infarction, stroke, or all-cause death) and CKD progression (50% decline of eGFR or ESKD). We used Cox proportional hazard models to test associations between baseline systolic BP with cardiovascular events and CKD progression. Results Cardiovascular events occurred in 52 participants and 161 had CKD progression during median follow-up times of 11.3 years and 4.1 years, respectively. Among those with baseline systolic BP ≥130 mm Hg, 3%/yr developed heart failure, 20%/yr had CKD progression, and 2%/yr died. In fully adjusted models, baseline systolic BP ≥130 mm Hg (versus systolic BP<120 mm Hg) was significantly associated with cardiovascular events or death (hazard ratio [HR], 2.13; 95% confidence interval [95% CI], 1.05 to 4.32) and CKD progression (HR, 1.68; 95% CI, 1.10 to 2.58). Conclusions Among young adults with CKD, higher systolic BP is significantly associated with a greater risk of cardiovascular events and CKD progression. Trials of BP management are needed to test targets and treatment strategies specifically in young adults with CKD." @default.
• W3133797170 created "2021-03-15" @default.
• W3133797170 creator A5010459902 @default.
• W3133797170 creator A5017557430 @default.
• W3133797170 creator A5067752300 @default.
• W3133797170 creator A5085683611 @default.
• W3133797170 date "2021-05-01" @default.
• W3133797170 modified "2023-10-12" @default.
• W3133797170 title "BP in Young Adults with CKD and Associations with Cardiovascular Events and Decline in Kidney Function" @default.
• W3133797170 cites W1974197757 @default.
• W3133797170 cites W1980817466 @default.
• W3133797170 cites W2004986510 @default.
• W3133797170 cites W2096512601 @default.
• W3133797170 cites W2096592656 @default.
• W3133797170 cites W2099838214 @default.
• W3133797170 cites W2105621177 @default.
• W3133797170 cites W2127917322 @default.
• W3133797170 cites W2133903170 @default.
• W3133797170 cites W2135233767 @default.
• W3133797170 cites W2142002753 @default.
• W3133797170 cites W2148983669 @default.
• W3133797170 cites W2155965977 @default.
• W3133797170 cites W2160134719 @default.
• W3133797170 cites W2160263067 @default.
• W3133797170 cites W2167540798 @default.
• W3133797170 cites W2189612961 @default.
• W3133797170 cites W2238977382 @default.
• W3133797170 cites W2341649724 @default.
• W3133797170 cites W2403503903 @default.
• W3133797170 cites W2419228228 @default.
• W3133797170 cites W2606106417 @default.
• W3133797170 cites W2736767046 @default.
• W3133797170 cites W2747721206 @default.
• W3133797170 cites W2748561040 @default.
• W3133797170 cites W2750093838 @default.
• W3133797170 cites W2753102265 @default.
• W3133797170 cites W2768267412 @default.
• W3133797170 cites W2786747959 @default.
• W3133797170 cites W2808227955 @default.
• W3133797170 cites W2900355037 @default.
• W3133797170 cites W2901938812 @default.
• W3133797170 cites W2915146734 @default.
• W3133797170 cites W2937832850 @default.
• W3133797170 cites W2954128667 @default.
• W3133797170 cites W2967346100 @default.
• W3133797170 cites W2967385951 @default.
• W3133797170 cites W3005637482 @default.
• W3133797170 cites W3032202176 @default.
• W3133797170 cites W4211142045 @default.
• W3133797170 cites W4211203344 @default.
• W3133797170 doi "https://doi.org/10.1681/asn.2020081156" @default.
• W3133797170 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8259674" @default.
• W3133797170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33692088" @default.
• W3133797170 hasPublicationYear "2021" @default.
• W3133797170 type Work @default.
• W3133797170 sameAs 3133797170 @default.
• W3133797170 citedByCount "7" @default.
• W3133797170 countsByYear W31337971702022 @default.
• W3133797170 countsByYear W31337971702023 @default.
• W3133797170 crossrefType "journal-article" @default.
• W3133797170 hasAuthorship W3133797170A5010459902 @default.
• W3133797170 hasAuthorship W3133797170A5017557430 @default.
• W3133797170 hasAuthorship W3133797170A5067752300 @default.
• W3133797170 hasAuthorship W3133797170A5085683611 @default.
• W3133797170 hasBestOaLocation W31337971701 @default.
• W3133797170 hasConcept C126322002 @default.
• W3133797170 hasConcept C127413603 @default.
• W3133797170 hasConcept C159641895 @default.
• W3133797170 hasConcept C164705383 @default.
• W3133797170 hasConcept C177713679 @default.
• W3133797170 hasConcept C1862650 @default.
• W3133797170 hasConcept C201903717 @default.
• W3133797170 hasConcept C205545832 @default.
• W3133797170 hasConcept C207103383 @default.
• W3133797170 hasConcept C23131810 @default.
• W3133797170 hasConcept C2778198053 @default.
• W3133797170 hasConcept C2778653478 @default.
• W3133797170 hasConcept C2780645631 @default.
• W3133797170 hasConcept C44249647 @default.
• W3133797170 hasConcept C500558357 @default.
• W3133797170 hasConcept C50382708 @default.
• W3133797170 hasConcept C50440223 @default.
• W3133797170 hasConcept C71924100 @default.
• W3133797170 hasConcept C78519656 @default.
• W3133797170 hasConcept C84393581 @default.
• W3133797170 hasConceptScore W3133797170C126322002 @default.
• W3133797170 hasConceptScore W3133797170C127413603 @default.
• W3133797170 hasConceptScore W3133797170C159641895 @default.
• W3133797170 hasConceptScore W3133797170C164705383 @default.
• W3133797170 hasConceptScore W3133797170C177713679 @default.
• W3133797170 hasConceptScore W3133797170C1862650 @default.
• W3133797170 hasConceptScore W3133797170C201903717 @default.
• W3133797170 hasConceptScore W3133797170C205545832 @default.
• W3133797170 hasConceptScore W3133797170C207103383 @default.
• W3133797170 hasConceptScore W3133797170C23131810 @default.
• W3133797170 hasConceptScore W3133797170C2778198053 @default.
• W3133797170 hasConceptScore W3133797170C2778653478 @default.
• W3133797170 hasConceptScore W3133797170C2780645631 @default.

• next